Zantac Compensation: Do You Have a Claim?
With the FDA issuing a full Zantac recall and warning that Zantac may cause cancer, Zantac lawsuits are piling up and many are wondering if they may qualify for Zantac compensation.
FEBRUARY 2023 UPDATE: Due to developments in the litigation, at this time we can no longer accept additional Zantac claims. Please stay tuned to our website for the latest information and updates.
Here’s what you need to know about potential Zantac compensation:
Zantac Cancer Risk: In late 2019, an independent lab found elevated levels of potentially cancer-causing NDMA in Zantac. The FDA confirmed these findings in early 2020. In a statement, the FDA said that levels of NDMA in Zantac and generic ranitidine are “unacceptably high.”
Lawsuits seeking Zantac compensation began to be filed around this time.
In April 2020, the FDA doubled down and issued a serious warning about potential Zantac cancer risk, requesting that all Zantac and ranitidine manufacturers stop selling the popular heartburn drugs. Patients taking over-the-counter Zantac were advised to stop taking Zantac immediately and those taking prescription Zantac were encouraged to contact their prescribing doctor immediately. Those taking Zantac are encouraged to seek Zantac alternatives.
At the same time, consumers and attorneys continued taking legal action, seeking Zantac compensation for cancer potentially caused by the heartburn drug.
Hundreds of Zantac lawsuits have now been filed, alleging that NDMA-contaminated Zantac caused various types of cancer, including:
- Kidney cancer
- Stomach cancer
- Liver cancer
- Bladder cancer
- Esophageal cancer
- Colorectal cancer
- Prostate cancer
- Pancreatic cancer
- Lung cancer (if you’ve never smoked)
- Intestinal cancer
These lawsuits seek Zantac compensation related to cancer potentially caused by Zantac. In February 2020, a federal panel sent more than 100 Zantac lawsuits to the Southern District of Florida, where they are now consolidated into Multidistrict Litigation (MDL) proceedings.
For more information about Zantac cancer risk and Zantac lawsuits, please visit our Zantac FAQ page.
FEBRUARY 2023 UPDATE: Due to developments in the litigation, at this time we can no longer accept additional Zantac claims. Please stay tuned to our website for the latest information and updates.
PLEASE NOTE: At this time, the federal MDL has limited the Zantac claims we can accept to bladder, esophageal, stomach, liver, and pancreatic cancers only. We understand that other cancers may be linked, but we are unfortunately unable to assist with these claims at this time due to evidence and recent court rulings.
Have you taken Zantac and been diagnosed with cancer?
FEBRUARY 2023 UPDATE: Due to developments in the litigation, at this time we can no longer accept additional Zantac claims. Please stay tuned to our website for the latest information and updates.
If you’ve taken brand-name Zantac and been diagnosed with any of the cancers listed above, you may be eligible for a Zantac lawsuit and have a claim for Zantac compensation.
For a FREE, no-obligation consultation with a Zantac cancer lawyer, please call 1-800-525-7111 or complete the short form below.
There is no obligation and you won’t pay any upfront costs or attorney fees unless we win your case.
Please call 1-800-525-7111 today and let’s review your case. You may be entitled to significant financial compensation for cancer potentially caused by Zantac.
IMPORTANT: A federal judge recently ruled against lawsuits concerning generic Zantac. At this point, we can only accept cases concerning use of brand-name Zantac OR “mixed” use of brand-name Zantac and generic equivalents.
Why Riddle & Brantley?
Riddle & Brantley has been holding drug companies accountable for more than three decades, and we are determined to hold manufacturers of Zantac and generic ranitidine accountable if these drugs caused cancer.
Our attorney have more than 220+ years of combined legal experience and we would love to help you get Zantac compensation if you’ve taken this drug and it resulted in cancer.
Our team is led by Gene Riddle, attorney and managing partner. Attorney Riddle is a member of Million Dollar Advocates Forum, Multi-Million Dollar Advocates Forum, Super Lawyers, and the National Trial Lawyers Top 100. In 2014, he was honored with the Litigator Award and he maintains the prestigious AV Preeminent rating from Martindale-Hubbell (see disclaimer below).
We strive to treat all clients like family and are proud to have won many five, six and seven-figure settlements and judgments on their behalf (see disclaimer below).
For a FREE consultation with an experienced Zantac cancer lawsuit attorney, please call 1-800-525-7111 or complete the short form below.
You may be entitled to compensation for your Zantac claim.
Please call 1-800-525-7111 today and let’s review your case.
Justice Counts for those who have been injured by dangerous drugs. We would love to help you seek justice and compensation if we can.
***Disclaimer: No settlement agreement has been reached in any litigation regarding ranitidine (ZANTAC®), including in the Multidistrict Litigation in the United States District Court for the Southern District of Florida (case no. 20-MD-2924).
*** Disclaimer: The results mentioned are intended to illustrate the type of cases handled by the firm. These results do not guarantee a similar outcome, and they should not be construed to constitute a promise or guarantee of a particular result in any particular case. Every case is different, and the outcome of any case depends upon a variety of factors unique to that case.
*** Disclaimer: An attorney must meet certain requirements to join these organizations or receive these awards. For more information on Membership Criteria for Million Dollar Advocates Forum, Multi-Million Dollar Advocates Forum, Super Lawyers, The National Trial Lawyers Top 100, AV Preeminent by Martindale-Hubbell, and the Litigator Award, please visit our Membership Criteria page. These awards and memberships should not be construed as a promise or guarantee of a similar result. Each case is different and must be evaluated separately.